Genetically engineered two-warhead evasins provide a method to achieve precision targeting of disease-relevant chemokine subsets

[1]  S. Bhattacharya,et al.  The N-terminal domain of a tick evasin is critical for chemokine binding and neutralization and confers specific binding activity to other evasins , 2018, The Journal of Biological Chemistry.

[2]  R. Payne,et al.  Ticks from diverse genera encode chemokine-inhibitory evasin proteins , 2017, The Journal of Biological Chemistry.

[3]  S. Bhattacharya,et al.  Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities , 2017, Scientific Reports.

[4]  R. Koenen,et al.  Chemokine interactome mapping enables tailored intervention in acute and chronic inflammation , 2017, Science Translational Medicine.

[5]  A. Verma,et al.  Pathogenic mechanisms of pancreatitis , 2017, World journal of gastrointestinal pharmacology and therapeutics.

[6]  Chengxin Zhang,et al.  PyMod 2.0: improvements in protein sequence‐structure analysis and homology modeling within PyMOL , 2016, Bioinform..

[7]  Kai A. Kropp,et al.  Chemokine binding proteins: An immunomodulatory strategy going viral. , 2016, Cytokine & growth factor reviews.

[8]  C. Power,et al.  Evasins: Therapeutic Potential of a New Family of Chemokine-Binding Proteins from Ticks , 2016, Front. Immunol..

[9]  Cristina Lebrero-Fernández,et al.  Murine Butyrophilin-Like 1 and Btnl6 Form Heteromeric Complexes in Small Intestinal Epithelial Cells and Promote Proliferation of Local T Lymphocytes , 2016, Front. Immunol..

[10]  D. Fremont,et al.  Parallel Evolution of Chemokine Binding by Structurally Related Herpesvirus Decoy Receptors. , 2016, Structure.

[11]  A. Koch,et al.  Successes and failures of chemokine-pathway targeting in rheumatoid arthritis , 2016, Nature Reviews Rheumatology.

[12]  Peter M Tessier,et al.  Advances in Antibody Design. , 2015, Annual review of biomedical engineering.

[13]  A. Alcamí,et al.  Immune modulation by virus-encoded secreted chemokine binding proteins. , 2015, Virus research.

[14]  Paolo Meda,et al.  Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection , 2015, PLoS pathogens.

[15]  N. Prats,et al.  Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation. , 2015, Pulmonary pharmacology & therapeutics.

[16]  C. Power,et al.  Targeting chemokines: Pathogens can, why can't we? , 2015, Cytokine.

[17]  A. Fernández-Sesma,et al.  Modulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory Drugs , 2015, Front. Immunol..

[18]  R. Couñago,et al.  Structures of Orf Virus Chemokine Binding Protein in Complex with Host Chemokines Reveal Clues to Broad Binding Specificity. , 2015, Structure.

[19]  S. Karim,et al.  An Insight into the Sialome of the Lone Star Tick, Amblyomma americanum, with a Glimpse on Its Time Dependent Gene Expression , 2015, PloS one.

[20]  D. Adams,et al.  Novel therapeutic targets in primary biliary cirrhosis , 2015, Nature Reviews Gastroenterology &Hepatology.

[21]  J. Ribeiro,et al.  The sialotranscriptome of Amblyomma triste, Amblyomma parvum and Amblyomma cajennense ticks, uncovered by 454-based RNA-seq , 2014, Parasites & Vectors.

[22]  F. Tacke,et al.  Roles for chemokines in liver disease. , 2014, Gastroenterology.

[23]  D. Leiman,et al.  Therapy of inflammatory bowel disease: what to expect in the next decade , 2014, Current opinion in gastroenterology.

[24]  N. Frangogiannis,et al.  The inflammatory response in myocardial injury, repair, and remodelling , 2014, Nature Reviews Cardiology.

[25]  A. Zernecke,et al.  Chemokines in Atherosclerosis: Proceedings Resumed , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Guangjie Chen,et al.  Chemokines and Chemokine Receptors in Multiple Sclerosis , 2014, Mediators of inflammation.

[27]  A. Mantovani,et al.  International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.

[28]  C. Power,et al.  Evasin-4, a tick-derived chemokine-binding protein with broad selectivity can be modified for use in preclinical disease models , 2013, The FEBS journal.

[29]  Frederick Klauschen,et al.  A Systems Analysis Identifies a Feedforward Inflammatory Circuit Leading to Lethal Influenza Infection , 2013, Cell.

[30]  H. Wasmuth,et al.  Chemokines in tissue fibrosis. , 2013, Biochimica et biophysica acta.

[31]  S. Brunak,et al.  Precision mapping of the human O‐GalNAc glycoproteome through SimpleCell technology , 2013, The EMBO journal.

[32]  Veerendra Kumar,et al.  Linkers in the structural biology of protein–protein interactions , 2013, Protein science : a publication of the Protein Society.

[33]  N. V. van Nuland,et al.  Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors. , 2012, Biochemical pharmacology.

[34]  J. Van Damme,et al.  Possible mechanisms involved in chemokine synergy fine tuning the inflammatory response. , 2012, Immunology letters.

[35]  Michael G. Katze,et al.  Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.

[36]  F. Mach,et al.  Role of cytokines and chemokines in non-alcoholic fatty liver disease. , 2012, World journal of gastroenterology.

[37]  T. Mabuchi,et al.  Chemokine receptors in the pathogenesis and therapy of psoriasis. , 2012, Journal of dermatological science.

[38]  J. Ribeiro,et al.  A Deep Insight into the Sialotranscriptome of the Gulf Coast Tick, Amblyomma maculatum , 2011, PloS one.

[39]  D. Stuart,et al.  Automation of large scale transient protein expression in mammalian cells , 2011, Journal of structural biology.

[40]  J. Woodcock,et al.  Development of novel combination therapies. , 2011, The New England journal of medicine.

[41]  A. Garin,et al.  Chemokines as targets for therapy. , 2011, Experimental cell research.

[42]  F. Mach,et al.  CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke , 2010, Thrombosis and Haemostasis.

[43]  J. Shaw,et al.  Structural Basis of Chemokine Sequestration by a Tick Chemokine Binding Protein: The Crystal Structure of the Complex between Evasin-1 and CCL3 , 2009, PloS one.

[44]  H. Katus,et al.  Autoimmune myocarditis: past, present and future. , 2009, Journal of autoimmunity.

[45]  Danfeng Yao,et al.  Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. , 2009, Combinatorial chemistry & high throughput screening.

[46]  P. Cockwell,et al.  Chemokines in vasculitis. , 2009, Frontiers in bioscience.

[47]  C. Bowlus,et al.  The immunobiology of primary sclerosing cholangitis , 2009, Seminars in Immunopathology.

[48]  Kai Griebenow,et al.  Effects of glycosylation on the stability of protein pharmaceuticals. , 2009, Journal of pharmaceutical sciences.

[49]  R. Horuk,et al.  Chemokine receptor antagonists: overcoming developmental hurdles , 2009, Nature Reviews Drug Discovery.

[50]  M. Teixeira,et al.  Ticks produce highly selective chemokine binding proteins with antiinflammatory activity , 2008, The Journal of experimental medicine.

[51]  Narayanan Eswar,et al.  Protein structure modeling with MODELLER. , 2008, Methods in molecular biology.

[52]  M. Teixeira,et al.  Molecular Cloning and Characterization of a Highly Selective Chemokine-binding Protein from the Tick Rhipicephalus sanguineus* , 2007, Journal of Biological Chemistry.

[53]  Narayanaswamy Srinivasan,et al.  Nucleic Acids Research Advance Access published June 21, 2007 PIC: Protein Interactions Calculator , 2007 .

[54]  Tracy M Handel,et al.  Chemokine: receptor structure, interactions, and antagonism. , 2007, Annual review of immunology.

[55]  R. Copeland,et al.  Drug–target residence time and its implications for lead optimization , 2007, Nature Reviews Drug Discovery.

[56]  Arne Skerra,et al.  The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins , 2007, Nature Protocols.

[57]  A. Sytkowski,et al.  Variability in the immunodetection of His-tagged recombinant proteins. , 2006, Analytical biochemistry.

[58]  K Dane Wittrup,et al.  Isolating and engineering human antibodies using yeast surface display , 2006, Nature Protocols.

[59]  Mitchell Ho,et al.  Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  A. Alcamí,et al.  Schistosoma mansoni secretes a chemokine binding protein with antiinflammatory activity , 2005, The Journal of experimental medicine.

[61]  S. Brunak,et al.  Improved prediction of signal peptides: SignalP 3.0. , 2004, Journal of molecular biology.

[62]  S. Moochhala,et al.  Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome , 2004, The Journal of pathology.

[63]  Martin A. Nowak,et al.  Antibody neutralization and escape by HIV-1 , 2003, Nature.

[64]  T. Schall,et al.  Comprehensive Mapping of Poxvirus vCCI Chemokine-binding Protein , 2002, The Journal of Biological Chemistry.

[65]  Elias Lolis,et al.  Structure, function, and inhibition of chemokines. , 2002, Annual review of pharmacology and toxicology.

[66]  Keith Dudley.  Short protocols in molecular biology , 1990 .

[67]  P. Wilkinson,et al.  Macrophage and Neutrophil Specific Chemotactic Factors in Serum , 1969, Nature.